Enhancing pigmentation via activation of A3 adenosine receptors in B16 melanoma cells and in human skin explants

Dioxinodehydroeckol inhibits melanin synthesis through PI3K/Akt signalling pathway in α-melanocyte-stimulating hormone-treated B16F10 cells

(2012) Min-Sup Lee et al.   EXPERIMENTAL DERMATOLOGY

Manassantin A inhibits cAMP-induced melanin production by down-regulating the gene expressions of MITF and tyrosinase in melanocytes

(2011) Hwa Dong Lee et al.   EXPERIMENTAL DERMATOLOGY

Ov-16 [4-(3,4-dihydroxybenzoyloxymethyl)phenyl-O-β-D-glucopyranoside] inhibits melanin synthesis by regulating expressions of melanogenesis-regulated gene and protein

(2011) Chia-Hua Liang   EXPERIMENTAL DERMATOLOGY

5,7-Dimethoxyflavone induces melanogenesis in B16F10 melanoma cells through cAMP-dependent signalling

(2011) Young-Gyu Kang et al.   EXPERIMENTAL DERMATOLOGY

Depigmenting action of platycodin D depends on the cAMP/Rho-dependent signalling pathway

(2011) Eunsun Jung et al.   EXPERIMENTAL DERMATOLOGY

Antioxidative characteristics and inhibition of α-melanocyte-stimulating hormone-stimulated melanogenesis of vanillin and vanillic acid from Origanum vulgare

(2010) Tzung-Han Chou et al.   EXPERIMENTAL DERMATOLOGY

“Transcription physiology” of pigment formation in melanocytes: central role of MITF

(2010) Jiri Vachtenheim et al.   EXPERIMENTAL DERMATOLOGY

What are melanocytesreallydoing all day long…?

(2009) P. M. Plonka et al.   EXPERIMENTAL DERMATOLOGY

Whitening activity of luteolin related to the inhibition of cAMP pathway in α-MSH-stimulated B16 melanoma cells

(2008) Mi Young Choi et al.   ARCHIVES OF PHARMACAL RESEARCH